Targeting ferroptosis as a vulnerability in pulmonary diseases

Cell Death Dis. 2022 Jul 26;13(7):649. doi: 10.1038/s41419-022-05070-7.

Abstract

Ferroptosis is an iron-dependent regulated cell death marked by excessive oxidative phospholipids (PLs). The polyunsaturated fatty acids-containing phospholipids (PUFA-PLs) are highly susceptible to lipid peroxidation under oxidative stress. Numerous pulmonary diseases occurrences and degenerative pathologies are driven by ferroptosis. This review discusses the role of ferroptosis in the pathogenesis of pulmonary diseases including asthma, lung injury, lung cancer, fibrotic lung diseases, and pulmonary infection. Additionally, it is proposed that targeting ferroptosis is a potential treatment for pulmonary diseases, particularly drug-resistant lung cancer or antibiotic-resistant pulmonary infection, and reduces treatment-related adverse events.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Fatty Acids, Unsaturated / metabolism
  • Ferroptosis*
  • Humans
  • Lipid Peroxidation
  • Lung Diseases*
  • Oxidation-Reduction
  • Phospholipids / metabolism

Substances

  • Fatty Acids, Unsaturated
  • Phospholipids